Advertisement

The Indian Journal of Pediatrics

, Volume 60, Issue 2, pp 289–298 | Cite as

Coxsackie virus infections in rheumatic fever

  • S. R. Zaher
  • A. S. Kassem
  • J. J. Hughes
Original Articles

Abstract

The close relationship between Group A beta Hemolytic Streptococci (GABS) and rheumatic fever is a well established one. However, the concept of the streptococcus as the sole etiologic agent of the rheumatic heart disease (RHD) has been challenged over the past years. Since coxsackievirus group B (CVB) has long been proposed as a cause of acquired valvular disease simulating rheumatic fever, we attempted in this study to document infections with this group of viruses in patients with rheumatic fever. We obtained blood samples from 106 patients with old (quiescent) rheumatic fever/rheumatic heart disease [group I], 94 patients with acute rheumatic fever (ARF) [group II], and 74 normal matched controls. We tested for the presence of neutralizing antibodies to the 6 serotypes of CVB by a micro neutralization test. We have found that infection with CVB, especially types B2 and B4, was common in the studied population. Forty two percent of normal individuals had evidence of infection with any of the 6 serotypes of CVB. Patients of group I had significantly more frequent infections with CVB 2. Patients in group II had significantly more frequent infections with CVB 2 and CVB 6. There was no clear correlation between such infections and the clinical course of rheumatic fever. There was no difference in the incidence of CVB infections between patients with definite ARF, and patients with suspected ARF. We set a low order association between rheumatic fever and infection with CVB types B2 and B6. We emphasize the importance of pursuing the investigation of the role of CVB in relation to RHD.

Key words

Rheumatic fever Coxsackie virus infections Rheumatic heart disease 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rammelkamp CH, Denny FW, Wannamaker LW. Studies on the epidemiology of rheumatic fever. In: Thomas L, ed. Rheumatic Fever. Minneapolis: University of Minnesota Press, 1952.Google Scholar
  2. 2.
    Swift HF. The etiology of rheumatic fever. Ann Intern Med 1949; 31 (5): 715.PubMedGoogle Scholar
  3. 3.
    Gordis L. The virtual disappearance of rheumatic fever in the U.S.: Lessons in the rise and fall of the disease. Circulation 1985; 72: 1155–1162.PubMedGoogle Scholar
  4. 4.
    Anonymous. Aetiology of acquired cardiac valve lesions. Br Med J 1980; 280: 1064.Google Scholar
  5. 5.
    Heymer B, Krause RM. Streptococcal infections and non suppurative complications. In: Samter A, ed. Immunological Diseases. Boston, Massachussets: Little Brown and Co Inc, 1979.Google Scholar
  6. 6.
    Markowitz M. Rheumatic fever in the eighties. Pediatr Clin North Am 1986; 33 (5): 1141–1149.PubMedGoogle Scholar
  7. 7.
    Burch GE, Giles TD, Colcolough HL. Pathogenesis of “rheumatic” heart disease: Critique and theory. Am Heart J 1970; 80 (4) 556–561.PubMedCrossRefGoogle Scholar
  8. 8.
    Ward C. Observations on the diagnosis of isolated rheumatic carditis. Am Heart J 1976; 91 (5): 545.PubMedCrossRefGoogle Scholar
  9. 9.
    Ward C. A reappraisal of the clinical features in acute and chronic rheumatic heart disease: Etiological implications. Am Heart J 1979; 98 (3): 298–306.PubMedCrossRefGoogle Scholar
  10. 10.
    Gordis L. Effectiveness of comprehensive-care programs in preventing rheumatic fever. N Engl J Med 1973; 289: 331–335.PubMedCrossRefGoogle Scholar
  11. 11.
    Markowitz M. Eradication of rheumatic fever. An unfulfilled hope. Circulation 1970; 41: 1077.PubMedGoogle Scholar
  12. 12.
    Sanyal SK, Berry AM, Duggal S et al. Sequelae of the initial attack of acute rheumatic fever in children from North India. A prospective 5-year follow-up study. Circulation 1982; 65 (2): 375–379.PubMedGoogle Scholar
  13. 13.
    Krause RM. Prevention of streptococcal sequelae by penicillin prophylaxis: A reassessment. J Infect Dis 1975;, 131 (5): 592–601.PubMedGoogle Scholar
  14. 14.
    Koontz CH, Ray CG. The role of coxsackievirus B infections in sporadic myopericarditis. Am Heart J 1971; 82 (6): 750–758.PubMedCrossRefGoogle Scholar
  15. 15.
    Burch GE, Giles TD. The role of viruses in the production of heart disease. Am J Cardiol 1972; 29: 231–240.PubMedCrossRefGoogle Scholar
  16. 16.
    Sainani GS. Adult heart disease due to Coxsackie virus B infection. Medicine 1968; 47 (2): 133–147.PubMedGoogle Scholar
  17. 17.
    Babb JM. Myocarditis and croup caused by coxsackie virus group B5. Arch Dis Child 1961; 36: 551.PubMedCrossRefGoogle Scholar
  18. 18.
    Burch GE et al. Coxsackie B viral myocarditis and valvulitis identified inroutine autopsy specimens by immunofluorescent techniques. Am Heart J 1967; 74 (1) 13–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Lau RCH. Coxsackie B virus infections in New Zealand patients with cardiac and non-cardiac diseases. J Med Virol 1983; 11: 131–137.PubMedCrossRefGoogle Scholar
  20. 20.
    Pongpanich B, Suthas NA Ayuthya P, Jayavasu J, Sangkavibha N. Coxsackie group B virus and acquired valvular heart disease in children. J Med Assoc Thai 1976; 59: 452–456.PubMedGoogle Scholar
  21. 21.
    Committee to revise the Jones Criteria of the council on rheumatic fever and congenital heart disease of the American Heart Association. Jones Criteria (Revised) for guidance, in the diagnosis of rheumatic fever. Circulation 1965; 32: 664.Google Scholar
  22. 22.
    Hierholzer JC, Bingham PG. Vero microcultures for adenovirus neutralization tests. J Clin Microbiol 1978; 7 (6): 499.PubMedGoogle Scholar
  23. 23.
    Hierholzer JC et al. Quantitation of enterovirus-70 antibody by microneutralization test and comparison with standard neutralization, hemagglutination inhibition, and complement fixation tests with different virus strains J Clin Microbiol 1984; 19: 826–830.PubMedGoogle Scholar
  24. 24.
    Lennette EH. Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections. 5th edn. Washington D.C.: American Public Health Association, Inc., 1979. 34–35.Google Scholar
  25. 25.
    Rosner B. Fundamentals of Biostatistics. 2nd edn. Boston, Massachusetts: Duxbury Press, 1986.Google Scholar
  26. 26.
    Ostle B. Statistics in Research. Basic Concepts and Techniques for Research Wokers. 2nd edn. Towa, USA: The Iowa State University Press, 1963: 56–57.Google Scholar
  27. 27.
    Sleight P, Jones JV. Scientific Foundations of Cardiology. London: William Heinemann Medical Books Ltd, 1983.Google Scholar
  28. 28.
    Grist NR, Bell EJ. A six-year study of Coxsackie virus B infections in heart disease. J Hyg (Camb) 1974; 73: 165–172.Google Scholar
  29. 29.
    Wattre P, Leroy O, Dewilde A, Thery C. Les infections a Coxsackie virus “B” en cardiologie. A propos de soixantesix observations. Path Biol 1987; 35 (4): 347–352.Google Scholar
  30. 30.
    Nicholls AC, Thomas M. Coxsackievirus infection in acute myocardial infarction. Lancet 1977; 1: 883–884.PubMedCrossRefGoogle Scholar
  31. 31.
    Griffithis PD, Hannington G, Booth JC. Coxsackievirus B infections and myocardial infarction. Lancet 1980; 1: 1387–1389CrossRefGoogle Scholar
  32. 32.
    Chandy KG, John TJ, Mukundan P, Cherian G. Coxsackie B antibodies in “rheumatic” valvular heart disease (Letter). Lancet 1979; 1: 381.PubMedCrossRefGoogle Scholar
  33. 33.
    Limson BM et al. Occurrence of infection with cosxackie B virus in rheumatic and non-rheumatic Filipino children. J Infect Dis 1979; 140 (3): 415.PubMedGoogle Scholar
  34. 34.
    Hamparian VV, Ottolenghi AC, Hughes JH. Enteroviruses in sludge: Multiyear experience with four wastewater treatment plants. Applied & Environmental Microbiol 1985; 50 (2): 280–286.Google Scholar
  35. 35.
    Melnick JL. Enteroviruses. In: Fields BN, ed. Virology. New York: Raven Press, 1985.Google Scholar
  36. 36.
    Smith WG. Adult heart disease due to cosxackievirus group B. Br Heart J 1966; 28: 204–219.PubMedCrossRefGoogle Scholar
  37. 37.
    Smith WG. Coxsackievirus B myopericarditis in adults. Am Heart J 1970; 80 (1): 34–46.PubMedCrossRefGoogle Scholar
  38. 38.
    Bell EJ, McCartney RA. A study of coxsackie virus B infections, 1972–1983. J Hyg (Camb) 1984; 93: 197–203.Google Scholar
  39. 39.
    Schmidt NJ, Magoffin RL, Lennette EH. Association of group B Coxsackie viruses with cases of pericarditis, myocarditis, or pleurodynia by demonstration of immunoglobulin M antibody. Infect Immunol 1973; 8: 341–348.Google Scholar
  40. 40.
    Lerner AM, Wilson FM, Reyes MP. Enteroviruses and the heart (with special emphasis on the probable role of coxsackie virus, group B, types 1–5). II. Observations in humans. Mod Conc Cardiovasc Dis 1975; 44 (3): 11–15.Google Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 1993

Authors and Affiliations

  • S. R. Zaher
    • 2
  • A. S. Kassem
    • 2
  • J. J. Hughes
    • 1
  1. 1.Department of MicrobiologyOhio State UniversityColumbusUSA
  2. 2.Department of PediatricsUniversity of Alexandria, El Shatby Hospital for ChildrenAlexandriaEgypt

Personalised recommendations